p53 mutation, deprivation and poor prognosis in primary breast cancer

BACKGROUND: The deprivation gap for breast cancer survival remains unexplained by stage at presentation, treatment, or co-morbidities. We hypothesised that p53 mutation might contribute to the impaired outcome observed in patients from deprived communities. METHODS: p53 mutation status was determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Baker, L, Quinlan, P R, Patten, N, Ashfield, A, Birse-Stewart-Bell, L-J, McCowan, C, Bourdon, J-C, Purdie, C A, Jordan, L B, Dewar, J A, Wu, L, Thompson, A M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2010
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837559/
https://www.ncbi.nlm.nih.gov/pubmed/20104224
http://dx.doi.org/10.1038/sj.bjc.6605540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2837559/
https://www.ncbi.nlm.nih.gov/pubmed/20104224
http://dx.doi.org/10.1038/sj.bjc.6605540

Ejemplares similares